You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Celgene

Showing 1026 - 1034 of 1,034
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in United States (CC-5013, liposomal doxorubicin)

Terminated
  • Ovarian Cancer
  • San Francisco, California
  • +4 more
Apr 10, 2006

HIV, HIV Wasting Syndrome Trial in Warren (Thalidomide)

Completed
  • HIV Infections
  • HIV Wasting Syndrome
  • Warren, New Jersey
    Celgene Corp
Jun 23, 2005

Prostate Cancer Trial in United States (CC5013)

Terminated
  • Prostate Cancer
  • Berkeley, California
  • +5 more
Nov 22, 2005

NSCLC Trial in United States (CC-5013, pemetrexed)

Terminated
  • Non-Small Cell Lung Cancer
  • Orlando, Florida
  • +4 more
Nov 2, 2005

Pancreatic Cancer Trial in United States (CC-5013, gemcitabine)

Terminated
  • Pancreatic Cancer
  • Metairie, Louisiana
  • +5 more
Nov 2, 2005

Fatigue, Tumors Trial in United States (dexmethylphenidate(d-mph))

Completed
  • Fatigue
  • Neoplasms
  • Birmingham, Alabama
  • +20 more
Jun 23, 2005

MDS Trial in United States (thalidomide)

Completed
  • Myelodysplastic Syndromes
  • La Jolla, California
  • +37 more
Jun 23, 2005

Melanoma, Tumor Metastasis Trial in Canada, United States (CC 5013)

Completed
  • Melanoma
  • Neoplasm Metastasis
  • CC 5013
  • Tucson, Arizona
  • +30 more
Jun 23, 2005

HIV, HIV Wasting Syndrome Trial in United States (Thalidomide)

Completed
  • HIV Infections
  • HIV Wasting Syndrome
  • Greenbrae, California
  • +12 more
Jun 23, 2005